Inventor
UROSEV DUNJA
CA12 patents
⚠️ This page may combine multiple inventors who share the name “UROSEV DUNJA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ZYMEWORKS INC
6 patentsUS9914785B2Mar 13, 2018
Engineered immunoglobulin heavy chain-light chain pairs and uses thereof
ZYMEWORKS INC17 citations91
US10077298B2Sep 18, 2018
Engineered immunoglobulin heavy chain-light chain pairs and uses thereof
ZYMEWORKS INC15 citations90
US11306156B2Apr 19, 2022
Modified antigen binding polypeptide constructs and uses thereof
ZYMEWORKS INC7 citations83
US11286293B2Mar 29, 2022
Engineered immunoglobulin heavy chain-light chain pairs and uses thereof
ZYMEWORKS INC6 citations83
US11161915B2Nov 2, 2021
Antigen-binding polypeptide constructs comprising kappa and lambda light chains and uses thereof
ZYMEWORKS INC7 citations83
US11078296B2Aug 3, 2021
Engineered immunoglobulin heavy chain-light chain pairs and uses thereof
ZYMEWORKS INC5 citations82
ZYMEWORKS BC INC
6 patentsUS12540198B2Feb 3, 2026
Antigen-binding polypeptide constructs comprising kappa and lambda light chains and uses thereof
ZYMEWORKS BC INC0 citations61
US12304945B2May 20, 2025
Engineered immunoglobulin heavy chain-light chain pairs and uses thereof
ZYMEWORKS BC INC0 citations60
US12286489B2Apr 29, 2025
Modified antigen binding polypeptide constructs and uses thereof
ZYMEWORKS BC INC0 citations60
US12060436B2Aug 13, 2024
Engineered immunoglobulin heavy chain-light chain pairs and uses thereof
ZYMEWORKS BC INC0 citations60
US11965019B2Apr 23, 2024
Stabilized chimeric Fabs
ZYMEWORKS BC INC0 citations47
US12433952B2Oct 7, 2025
Antibody-drug conjugates targeting folate receptor alpha and methods of use
ZYMEWORKS BC INC0 citations38